ResearchGuide Logo

Chat support

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Quartille





VacciMonitor

VERIFIED JOURNAL
You want to contribute ? Login first and send us the Journal infos you think is correct.
We would be pleased to have your collaboration

This journal is included in the ResearchGuide whitelist of reputable titles. Learn more here.

JOURNAL INFORMATION
Publisher Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros
Open Access NO
Quartile Q4
Citation Count 8
P-ISSN 1025-0298
E-ISSN 1025-028X
Categories Drug Discovery, Immunology, Immunology and Allergy, Molecular Medicine
Area Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine, Pharmacology, Toxicology and Pharmaceutics
Region Latin America
Country Cuba
Summary

  1. VacciMonitor is published by Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros
  2. It is not an oppen access journal
  3. The Subject Area : Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics

Latest Articles published

Last updated: 30/09/2024

Preparation and evaluation of a bivalent peste des petits ruminants and Brucella Rev-1 vaccine for sheep


Last updated: 30/09/2024

Challenges of vaccine politics: implications for addressing hesitancy


Last updated: 30/09/2024

A cross-sectional assessment of refusal factors towards polio vaccination


Last updated: 12/08/2024

Effect of inactivated and mRNA COVID-19 vaccines on thrombocytopenia in immune thrombocytopenia patients


Last updated: 01/07/2024

Evaluation of a prepared combined inactivated vaccine against hemorrhagic disease virus 2 and Clostridium perfringens type A infections in rabbit


Last updated: 03/06/2024

Capacidad de procesamiento de los nanofiltros empleados en la purificación de la proteína recombinante del dominio de unión al receptor del coronavirus tipo 2 del síndrome respiratorio agudo severo


Last updated: 03/06/2024

Vacunación con SOBERANA®02 y SOBERANA®Plus en trabajadores: éxito en el enfrentamiento a la pandemia de COVID-19


Last updated: 27/05/2024

Establecimiento del esquema de purificación de los antígenos de SOBERANA®02, SOBERANA®Plus y SOBERANA 01


Last updated: 27/05/2024

Efficacy of current vaccines against recently isolated foot and mouth disease virus type A South America (Venezuela) in Egypt 2022


Last updated: 27/05/2024

Using guinea pig as a model for evaluation of equine influenza vaccine